StockData

JRSIS HEALTH CARE Corp (JRSS) stock

JRSSOTCServices-HospitalsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Dec 20, 2024
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.10MP/E –Yield –

Jrsis Health Care r&d expenses

Research and development expenses are spending on new products and technology.

Jrsis Health Care's R&D Expenses for the twelve months ending Sep 30, 2024 was $133.12K. For fiscal 2023 it was $189.27K, down 33.1% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2023Dec 31, 2023$189.27K-33.1%
FY2022Dec 31, 2022$283.04K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024$28.84K-20.3%
Q2 FY2024Jun 30, 2024$9.60K-75.0%
Q1 FY2024Mar 31, 2024$10.25K-66.2%
Q4 FY2023Dec 31, 2023$84.43K–
Q3 FY2023Sep 30, 2023$36.20K–
Q2 FY2023Jun 30, 2023$38.34K–
Q1 FY2023Mar 31, 2023$30.30K–

More Jrsis Health Care figures

See a number that looks wrong?